The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jerel Davis since 2020.
This trader's CIK number is 1745958.
At the time of last reporting, Jerel Davis was the Director of Turnstone Biologics Corp.. (stock ticker symbol TSBX).
Also see all insider trading activities at Turnstone Biologics Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | RPTX | 0 | $0 | 750,000 | $9,189,000 | 0 | $0 |
| 2020 | RPTX | 250,000 | $5,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KDNY | 0 | $0 | 695,808 | $15,238,311 | 3,300 | $0 |
| 2022 | KDNY | 0 | $0 | 1,000,000 | $16,000,000 | 0 | $0 |
| 2021 | KDNY | 0 | $0 | 850,000 | $11,900,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TSBX | 225,000 | $2,700,000 | 0 | $0 | 0 | $0 |
1. Repare Therapeutics Inc. (RPTX)
2. Chinook Therapeutics, Inc. (KDNY)
3. Turnstone Biologics Corp. (TSBX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-03 | RPTX | Sale | 750,000 | 12.25 | 9,189,000 |
| 2020-06-23 | RPTX | Buy | 250,000 | 20.00 | 5,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-26 | KDNY | Option Ex | 3,300 | .00 | 0 |
| 2023-04-17 | KDNY | Sale | 295,808 | 20.75 | 6,138,311 |
| 2023-03-01 | KDNY | Sale | 400,000 | 22.75 | 9,100,000 |
| 2022-01-03 | KDNY | Sale | 1,000,000 | 16.00 | 16,000,000 |
| 2021-08-27 | KDNY | Sale | 850,000 | 14.00 | 11,900,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-25 | TSBX | Buy | 225,000 | 12.00 | 2,700,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jerel Davis (Director of Turnstone Biologics Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.